Breaking News Instant updates and real-time market news.

ADBE

Adobe

$175.00

-1.83 (-1.03%)

05:03
12/15/17
12/15
05:03
12/15/17
05:03

Adobe price target raised to $202 from $177 at Citi

Citi analyst Walter Pritchard raised his price target for Adobe Systems to $202 saying last night's were strong where they needed to be. Adobe posted very solid Digital Media results and renewed stability in Digital Marketing, Pritchard tells investors in a post-earnings research note. He expects the company can compound earnings and cash flow 20% annually over next three years and keeps a Buy rating on the shares.

ADBE Adobe
$175.00

-1.83 (-1.03%)

12/12/17
12/12/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Juno Therapeutics (JUNO) downgraded to Market Perform from Outperform at Wells Fargo, with analyst Jim Birchenough saying that while data for JCAR017 continue to support a potential best-in-class profile in aggressive lymphoma, the current valuation already reflects dominant market positioning over Gilead's (GILD) Yescarta. 2. General Dynamics (GD) downgraded to Underweight from Neutral at JPMorgan, with analyst Seth Seifman saying Gulfstream questions are unlikely to be resolved in the near term. Demand for G500/600 is ok for now, but uncertainty about ultimate production levels and the pace of the learning curve mean the transition will remain a near term overhang, the analyst said. Seifman also downgraded Raytheon (RTN) to Neutral from Underweight. 3. Adobe (ADBE), Barracuda (CUDA), GoDaddy (GDDY), Fortinet (FTNT) and Check Point (CHKP) downgraded to Neutral from Overweight and CoStar Group (CSGP), Imperva (IMPV) and Monotype Imaging (TYPE) downgraded to Underweight from Overweight at JPMorgan by analyst Sterling Auty in conjunction with his 2018 annual outlook for Software Technology. The analyst does not expect the "exceptional performance" in Software during 2017 to repeat in 2018. 4. Spark Therapeutics (ONCE) downgraded to Neutral from Buy at UBS, with analyst Carter Gould seeing a "challenging setup" for the shares after the Phase 1/2 SPK-8011 data in hemophilia A fell short of expectations. The analyst removed SPK-8011, or $29 per share, and early-stage pipeline value, or $12 per share, from his model. He finds it difficult to be more constructive on Spark shares in the near-term. 5. Electronic Arts (EA) downgraded to Buy from Conviction Buy at Goldman Sachs by analyst Christopher Merwin to reflect fewer near-term catalysts around in-game monetization of non-sports titles. To see The Fly's full Street Research coverage, click here.
12/13/17
MSCO
12/13/17
NO CHANGE
Target $186
MSCO
Equal Weight
Adobe price target raised to $186 ahead of Q4 earnings at Morgan Stanley
Morgan Stanley analyst Keith Weiss previewed Adobe's Q4 earnings report, stating that his channel checks with partners signal strong demand trends with healthy Creative Cloud renewal rates and solid traction in Document Cloud. Updating his forecast to include EPS growth of over 20% into FY19 leads Weiss to raise his price target on Adobe shares to $186 from $155. He maintains an Equal Weight rating on the stock ahead of the company's Q4 report, scheduled for Thursday, December 14.
12/13/17
BOFA
12/13/17
NO CHANGE
Target $220
BOFA
Buy
Adobe price target raised to $220 from $213 at BofA/Merrill
BofA/Merrill analyst Kash Rangan raised his price target for Adobe (ADBE) to $220 from $213 ahead of quarterly results. The analyst notes that investors are concerned that the company is losing to competition especially Salesforce (CRM) but marketing growth is not as strong a driver for stock price as digital media growth and profitability metrics are. His channel checks suggest that Adobe is still leader in B2C and is becoming more relevant in B2B. Further, he adds that he could see an e-commerce related acquisition in the future that can consolidate B2B position. Rangan reiterates a Buy rating on Adobe's shares.
12/15/17
LEHM
12/15/17
NO CHANGE
Target $193
LEHM
Overweight
Adobe price target raised to $193 from $181 at Barclays
Barclays analyst Saket Kalia raised his price target for Adobe Systems to $193 citing last night's "strong" Q4 results. The analyst believes tax reform could be positive for the company and keeps an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

PDCO

Patterson Companies

$21.80

-0.3 (-1.36%)

07:09
05/23/18
05/23
07:09
05/23/18
07:09
Hot Stocks
Patterson Companies announces Donald Zurbay as CFO, Andrea Frohning as CHRO »

Patterson Companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$39.22

-0.33 (-0.83%)

07:09
05/23/18
05/23
07:09
05/23/18
07:09
Recommendations
Mylan analyst commentary  »

Mylan risk/reward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

TIF

Tiffany

$102.26

-0.96 (-0.93%)

07:09
05/23/18
05/23
07:09
05/23/18
07:09
Technical Analysis
Technical Take: Tiffany hits a new life high after results »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 26

    Jun

CMTA

Clementia Pharmaceuticals

$18.80

0.26 (1.40%)

07:08
05/23/18
05/23
07:08
05/23/18
07:08
Conference/Events
Clementia Pharmaceuticals to hold a pharmaceutical update conference call »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMST

HomeStreet

$28.15

-0.2 (-0.71%)

07:08
05/23/18
05/23
07:08
05/23/18
07:08
Hot Stocks
HomeStreet urges shareholders to vote on company's proxy card »

HomeStreet issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

MEOH

Methanex

$70.40

(0.00%)

07:08
05/23/18
05/23
07:08
05/23/18
07:08
Recommendations
Methanex analyst commentary  »

Methanex price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLRX

Valeritas

$1.52

-0.05 (-3.18%)

07:06
05/23/18
05/23
07:06
05/23/18
07:06
Hot Stocks
Valeritas' V-Go device shows benefits in type 2 diabetes »

Valeritas announced data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUB

Cubic

$70.40

-1.35 (-1.88%)

07:05
05/23/18
05/23
07:05
05/23/18
07:05
Hot Stocks
Cubic's CTS unit awarded contract from SRTA in Atlanta »

Cubic Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

TGT

Target

$75.42

-1.44 (-1.87%)

07:05
05/23/18
05/23
07:05
05/23/18
07:05
Technical Analysis
Technical Take: Target falls sharply after earnings miss »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 19

    Jun

REX

REX American Resources

$76.62

-0.5 (-0.65%)

07:05
05/23/18
05/23
07:05
05/23/18
07:05
Earnings
REX American Resources reports Q1 EPS $1.45 vs. 69c last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

ALKS

Alkermes

$45.58

0.35 (0.77%)

07:04
05/23/18
05/23
07:04
05/23/18
07:04
Hot Stocks
Alkermes to present data on depression, schizophrenia portfolios at ASCP »

Alkermes announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 31

    Jan

KOOL

Cesca Therapeutics

$0.53

0.0307 (6.14%)

07:04
05/23/18
05/23
07:04
05/23/18
07:04
Initiation
Cesca Therapeutics initiated  »

Cesca Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCI

Navigant Consulting

$24.00

-0.19 (-0.79%)

07:04
05/23/18
05/23
07:04
05/23/18
07:04
Hot Stocks
Navigant Consulting, Lumere announce collaboration to reduce clinical variation »

Navigant Consulting and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

ACRX

AcelRx

$2.95

0.05 (1.72%)

07:03
05/23/18
05/23
07:03
05/23/18
07:03
Hot Stocks
Three Arch's shares of AcelRx stock acquired in deal led by Leerink Revelation »

AcelRx Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:02
05/23/18
05/23
07:02
05/23/18
07:02
General news
MBA Mortgage Applications Composite Index data reported »

Week of 5/18 MBA Mortgage…

ANTM

Anthem

$234.12

0.52 (0.22%)

07:02
05/23/18
05/23
07:02
05/23/18
07:02
Hot Stocks
Anthem to acquire Aspire Health, financial terms not disclosed »

Anthem announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MINE

Minerco Resources

$0.00

(0.00%)

07:02
05/23/18
05/23
07:02
05/23/18
07:02
Hot Stocks
Minerco acquires controlling interest in Priwen Systems »

Minerco announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XCRA

Xcerra

$14.01

0.31 (2.26%)

07:02
05/23/18
05/23
07:02
05/23/18
07:02
Earnings
Xcerra reports Q3 non-GAAP EPS 24c, consensus 20c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

SO

Southern Company

$43.55

0.13 (0.30%)

07:01
05/23/18
05/23
07:01
05/23/18
07:01
Hot Stocks
Southern Power to sell minority stake in solar portfolio for $1.175B to GAFG »

Southern Power, a U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SPX

S&P 500

$0.00

(0.00%)

07:00
05/23/18
05/23
07:00
05/23/18
07:00
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACM

Aecom

$33.33

-0.02 (-0.06%)

07:00
05/23/18
05/23
07:00
05/23/18
07:00
Hot Stocks
Aecom awarded 15-year $3.1B U.S. Air Force contract »

AECOM's wholly owned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AET

Aetna

$177.66

0.08 (0.05%)

, CVS

CVS Health

$65.59

0.09 (0.14%)

06:58
05/23/18
05/23
06:58
05/23/18
06:58
Recommendations
Aetna, CVS Health analyst commentary  »

Aetna risk/reward…

AET

Aetna

$177.66

0.08 (0.05%)

CVS

CVS Health

$65.59

0.09 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

FTR

Frontier Communications

$9.55

-0.06 (-0.62%)

06:58
05/23/18
05/23
06:58
05/23/18
06:58
Periodicals
Frontier in talks with bondholders after failed asset auction, Bloomberg reports »

Frontier Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$39.46

-4.14 (-9.50%)

06:55
05/23/18
05/23
06:55
05/23/18
06:55
Recommendations
Toll Brothers analyst commentary  »

Toll Brothers price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$183.81

-0.67 (-0.36%)

06:53
05/23/18
05/23
06:53
05/23/18
06:53
Periodicals
Facebook's upper ranks never seem to leave company, Recode reports »

Facebook's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.